Trademark: 97664916
Word
NEXT GENERATION RADIOLIGANDS
Status Date
Tuesday, May 21, 2024
Filing Date
Sunday, November 6, 2022
Published for Opposition
Tuesday, May 21, 2024
5 Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Nov 9, 2022
New Application Entered
Nov 23, 2022
New Application Office Supplied Data Entered
Aug 21, 2023
Assigned To Examiner
Aug 24, 2023
Non-Final Action Written
Aug 24, 2023
Non-Final Action E-Mailed
Aug 24, 2023
Notification Of Non-Final Action E-Mailed
Nov 20, 2023
Application Extension To Response Period - Received
Nov 20, 2023
Application Extension Granted/Receipt Provided
Feb 14, 2024
Teas Response To Office Action Received
Feb 14, 2024
Correspondence Received In Law Office
Feb 15, 2024
Teas/Email Correspondence Entered
Mar 12, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 12, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 12, 2024
Teas Change Of Correspondence Received
Apr 15, 2024
Non-Final Action Written
Apr 15, 2024
Non-Final Action E-Mailed
Apr 15, 2024
Notification Of Non-Final Action E-Mailed
Apr 16, 2024
Teas/Email Correspondence Entered
Apr 16, 2024
Correspondence Received In Law Office
Apr 16, 2024
Teas Response To Office Action Received
Apr 18, 2024
Approved For Pub - Principal Register
May 1, 2024
Notification Of Notice Of Publication E-Mailed
May 21, 2024
Published For Opposition
May 21, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
